Catalyst Wire Dossier Catalyst Wire Dossier

Pradaxar

dabigatran · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pradaxar, covering 2012-04-05 to 2012-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

See pricing